Sign Up to like & get
recommendations!
2
Published in 2022 at "Drug Development Research"
DOI: 10.1002/ddr.21962
Abstract: A series of [1,2]oxazolo[5,4‐e]isoindole derivatives was evaluated against HL‐60 cell line and its multidrug resistance (MDR) variant, HL‐60R, resistant to doxorubicin and to other P‐gp substrates by overexpressing the efflux pump. They displayed antiproliferative activities,…
read more here.
Keywords:
cell;
cell line;
oxazolo isoindoles;
insights oxazolo ... See more keywords